- AKBA +0.75%
When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)?
Yahoo Finance · 1 hour ago
Open | 1.3400 |
High | 1.3500 |
Low | 1.2950 |
Mkt Cap | 280.56M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 1.3300 |
52 Wk. Low | 0.7800 |
52 Wk. High | 2.4800 |
Related stocks
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 56.2M | 0.70% ▲ |
Net Income | 614k | - |
Diluted EPS | 0.00 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$0.08 | - |
Q4 2023 | -$0.04 | $0.00 |
Q3 2023 | -$0.08 | -$0.08 |
S&P 500^GSPC | 5,099.96+51.54 (+1.02%) |
Dow 30^DJI | 38,239.66+153.86 (+0.40%) |
Nasdaq^IXIC | 15,927.90+316.14 (+2.03%) |
Ethereum USDETH-USD | 3,316.77+5.56% |
39.58+0.76% | |
80.22+0.97% |